Month: December 2017

Zumiez Inc. ZUMZ has been able to maintain its robust performance amid tough retail scenario. This along with the company’s solid comps performance and strategic initiatives, including new customer engagement, store expansion and e-commerce growth bode well for the stock […]

The United States Senate just passed the Tax Cuts and Jobs Act, marking President Donald Trump’s first major legislative conquest. The highlight of the reform is the slash in corporate tax rate from 35% to 20% that is expected to boost the bottom line of the companies. However, the technology sector is unlikely to benefit much from the reforms owing to the fact that it already enjoys several tax benefits and therefore has a lower effective tax rate […]

NCR Corporation NCR recently announced the sale of the remaining assets of its Interactive Printer Solutions (IPS) division — located in the Middle East and Africa (MEA) region — to Interactive Printer Solutions FZCO (IPS FZCO), a part of the Turbon Group of Companies. The deal included the IPS manufacturing facilities of Jebel Ali Free Zone in Dubai, IPS distribution centers and its employees. Per the latest contract, the acquirer will maintain a commercial relationship with NCR post the transaction […]

It is a well-established fact that the widely-diversified transportation sector including airline companies, railroads, truckers, shippers to name a few, has struggled for the better part of 2017. Sector participants have been plagued by a number of headwinds like disruptions from back-to-back hurricanes, the devastating earthquake in Mexico, declining automotive volumes, issues related to customer dissatisfaction and high costs (labor as well as fuel). […]

Shares of Celgene Corporation CELG were down after the company reported disappointing data from the phase III study, RELEVANCE, on Revlimid in combination with Roche Holdings RHHBY ’s Rituxan for treatment-naïve follicular lymphoma. The study evaluated Revlimid plus Rituxan (R2) followed by R2 maintenance compared with the standard of care featuring Rituxan plus chemotherapy (R-CHOP, R-bendamustine or R-VN CVP) followed by Rituxan maintenance on patients with previously untreated for follicular lymphoma. However, the R2 treatment arm could not achieve superiority in the co-primary endpoints of complete response or unconfirmed complete response CR/CRu) at 120 weeks and in terms of progression-free survival (PFS) observed during the pre-planned analysis. […]

Despite posting dismal results since its IPO in June 2015, the stock price movement of Teladoc Inc. TDOC , a telehealth service provider, paints a different picture. Stock price which is often significantly influenced by earnings is not replicated in case of Teladoc. […]

Integrated energy stocks have been flying high on elevated oil prices, driven by robust global demand and tight supplies. The resurgence in oil prices on the one hand and strong cash flow from operations on the other helped the sector. Riding on the momentum, shares of oil majors such as Chevron Corp […]

With 2017 at its threshold, investors have many reasons to cheer for. The economic backdrop has improved with GDP rising, improving employment scenario and major indices gaining year to date. While the S&P 500 has rallied 20.3%, Nasdaq has gained 12.3%. […]

The overall market performance has been great in 2017. With gradual improvement in the U.S. economy, rising rate environment, potential benefits from lower tax rates and growing investor optimism regarding reduced regulations, the banking industry has emerged as one of the best performers this year […]

Apple’s AAPL Shazam acquisition, its $390 million advance to Finisar FNSR and Western Digital WDC making peace with Toshiba were the top news from last week. Here are the details- Apple Buys Shazam Apple has acquired popular music discovery app Shazam for an estimated $400 million. Shazam identifies music playing near the device within a few seconds and directs users to places like Apple’s App Store or Google’s Play Store where they can listen to the whole track later. […]

The medical devices industry, which was once acclaimed for its high-paying jobs and research and development opportunities, has been subject to the much controversial 2.3% medical device excise tax. The MedTech fraternity is leaving no stone unturned to permanently do away with the dreadful tax — but has not been able to. Interestingly, the year 2017 has been quite an eventful one, courtesy of a series of socio-political occurrences that favored the space […]

Altice USA Inc ATUS and TiVo Corporation TIVO have reportedly signed an extended six-year patent agreement. The deal extends Altice USA’s license to TiVo’s patent portfolios and will broadcast new features across the newly-formed platform — Altice One. Altice USA, based in Bethpage, NY, is one of the largest broadband communications and video services providers […]

Shares of Biogen Inc. BIIB declined by almost 3.3% after the company’s Alzheimer's candidate, BAN2401, failed to meet the criteria for success based on a 12-months interim analysis as the primary endpoint in a mid-stage trial. The company is developing the candidate in collaboration with Eisai Co., Ltd […]

Hyatt Hotels Corporation H yesterday announced the expansion of its Hyatt Centric brand in Europe. Per the press release, Hyatt Centric Gran Via Madrid, the first Hyatt hotel in mainland Spain opened on Dec 20. The 159-room hotel is situated in the heart of the capital city of Madrid along the Gran Via. […]